Last edition
News about Drug Discovery & Development
Mediar Therapeutics, Ono Pharma Enter Collaboration to Develop Novel Fibrosis Therapies
Mediar Therapeutics and Ono Pharmaceutical have entered a collaboration and option agreement to discover novel therapies targeting fibro-inflammatory diseases, while Mediar advances its pipeline of fibrosis-focused antibody programmes.
Drug Discovery & Development | 10/08/2026 | By News Bureau
BARDA Boosts Funding for Basilea's Investigational Oral Antibiotic Targeting Drug-Resistant UTIs
Basilea Pharmaceutica has secured an additional USD 5.4 million from BARDA to accelerate the development of its investigational oral antibiotic ceftibuten-ledaborbactam etzadroxil, a potential treatment for complicated urinary tract infections caused by multidrug-resistant Gram-negative pathogens.
Drug Discovery & Development | 06/08/2026 | By News Bureau | 105
Pathos AI, AstraZeneca Partner to Advance AI-Driven Breast Cancer Therapy into Clinical Development
Pathos AI and AstraZeneca have entered a strategic collaboration to advance AZD4241, an investigational therapy for ER+/HER2- breast cancer, using artificial intelligence to enhance clinical development and precision oncology.
Drug Discovery & Development | 05/08/2026 | By News Bureau | 120
ICAR Develops India's First Indigenous Vaccine Against African Swine Fever
The MA-104 cell line-based live attenuated vaccine offers cost-effective, large-scale protection against African swine fever, aiming to reduce pig mortality, safeguard farmers' livelihoods and strengthen India's animal health security.
Drug Discovery & Development | 05/08/2026 | By News Bureau | 106
IIT Kanpur Scientists' Research Reveals How a Promising Vaccine Booster Switches on Immune Cells
IIT Kanpur scientists have uncovered how the vaccine booster candidate EP67 activates immune cells, paving the way for safer vaccines and immune therapies.
Drug Discovery & Development | 24/07/2026 | By News Bureau | 104
New patient-derived xenograft study demonstrates strong synergy between GLIX1 and PARP inhibitors in HR-proficient ovarian cancer, paving the way for expanded clinical evaluation in Phase 1/2a trials.
Drug Discovery & Development | 09/07/2026 | By News Bureau | 106
The rise of GLP-1 therapies has transformed diabetes and obesity treatment. Following semaglutide patent expiry in India in March 2026, multiple companies entered the market simultaneously. Pharma Industrial India spoke with industry leaders about the opportunities, challenges, and future of this rapidly evolving therapeutic segment.
Drug Discovery & Development | 26/06/2026 | By Akanki | 152
Simcere Pharmaceutical and Stanford Medicine Partner on IPF Therapy Research
Simcere Pharmaceutical has entered a research collaboration with Stanford Medicine to develop innovative therapies for Idiopathic Pulmonary Fibrosis (IPF).
Drug Discovery & Development | 16/06/2026 | By News Bureau | 151
Pfizer and Innovent Biologics Partner to Advance Global Oncology Drug Development
Pfizer and Innovent Biologics have entered a global strategic collaboration to develop innovative oncology medicines, combining 12 discovery and early-stage programs to accelerate cancer drug development through shared research, clinical development, and commercialisation efforts.
Drug Discovery & Development | 29/05/2026 | By News Bureau | 152
The Lupus Research Alliance and Genentech announce inaugural recipients of the Immune Resetting Therapies for Lupus Award to accelerate research into CAR-T cell therapies for severe lupus patients.
Drug Discovery & Development | 28/05/2026 | By News Bureau | 187
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy